LY96 and heart failure: Mechanistically, artesunate binds to the co-receptor MD2, allosterically inhibiting its interaction with TLR4 and thereby blocking downstream profibrotic signaling pathways, positioning artesunate as an intriguing candidate for drug repurposing in the treatment of cardiac fibrosis and heart failure.